Published in AIDS Res Ther on September 28, 2012
Clinical review: Respiratory failure in HIV-infected patients--a changing picture. Crit Care (2013) 0.78
Clinical Characteristics and Short-Term Outcomes of HIV Patients Admitted to an African Intensive Care Unit. Crit Care Res Pract (2016) 0.75
Six-month survival of critically ill patients with HIV-related disease and tuberculosis: a retrospective study. BMC Infect Dis (2016) 0.75
Improved Outcomes in Critically Ill Patients With AIDS: How Does This Trend Continue? Crit Care Med (2016) 0.75
Characteristics and outcomes of HIV-1-infected patients with acute respiratory distress syndrome. J Crit Care (2014) 0.75
Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med (2001) 51.99
Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med (2000) 48.03
Intensive insulin therapy in critically ill patients. N Engl J Med (2001) 40.00
A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA (1994) 27.36
Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med (2010) 10.90
Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS One (2009) 4.52
HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population. J Acquir Immune Defic Syndr (2007) 3.38
Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa. Clin Infect Dis (2010) 3.25
Intensive care of patients with HIV infection. N Engl J Med (2006) 2.86
Intensive care in patients with HIV infection in the era of highly active antiretroviral therapy. Chest (2004) 2.26
Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia. AIDS (2003) 2.18
Intensive care of human immunodeficiency virus-infected patients during the era of highly active antiretroviral therapy. Am J Respir Crit Care Med (2002) 2.12
Survival for patients With HIV admitted to the ICU continues to improve in the current era of combination antiretroviral therapy. Chest (2008) 1.94
Predictors of short- and long-term survival in HIV-infected patients admitted to the ICU. Chest (1998) 1.75
Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit. AIDS (2004) 1.73
Adding up the Glasgow Coma Score. Acta Neurochir Suppl (Wien) (1979) 1.46
Outcomes of intensive care for patients with human immunodeficiency virus infection. Arch Intern Med (2000) 1.39
Outcome of critically ill human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. J Intensive Care Med (2005) 1.29
Benefit of antiretroviral therapy on survival of human immunodeficiency virus-infected patients admitted to an intensive care unit. Crit Care Med (2009) 1.24
Effect of antiretroviral therapy on admissions of HIV-infected patients to an intensive care unit. HIV Med (2006) 1.22
Improving outcome of human immunodeficiency virus-infected patients in a Mexican intensive care unit. Arch Med Res (2007) 0.97
Low tidal volume ventilation is associated with reduced mortality in HIV-infected patients with acute lung injury. Thorax (2008) 0.96
Critical care of patients with AIDS. JAMA (1992) 0.89
A communication strategy and brochure for relatives of patients dying in the ICU. N Engl J Med (2007) 10.13
Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire. N Engl J Med (2006) 5.62
Induced hypothermia in severe bacterial meningitis: a randomized clinical trial. JAMA (2013) 2.97
Scaling up antiretroviral therapy in South Africa: the impact of speed on survival. J Infect Dis (2008) 2.96
Inhibition of bacterial RNA polymerase by streptolydigin: stabilization of a straight-bridge-helix active-center conformation. Cell (2005) 2.88
Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures. Clin Infect Dis (2005) 2.67
Transparent development of the WHO rapid advice guidelines. PLoS Med (2007) 2.57
Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. J Hepatol (2005) 2.45
Effect of gingival and dental plaque antiseptic decontamination on nosocomial infections acquired in the intensive care unit: a double-blind placebo-controlled multicenter study. Crit Care Med (2005) 2.37
Vitamin D deficiency in HIV-infected patients: associated with non-nucleoside reverse transcriptase inhibitor or efavirenz use? AIDS (2011) 2.23
Important questions asked by family members of intensive care unit patients. Crit Care Med (2011) 2.22
Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: a modeling approach. Hepatology (2014) 2.05
Impact of drug stock-outs on death and retention to care among HIV-infected patients on combination antiretroviral therapy in Abidjan, Côte d'Ivoire. PLoS One (2010) 2.05
Different Polycomb group complexes regulate common target genes in Arabidopsis. EMBO Rep (2006) 2.02
Six-week versus twelve-week antibiotic therapy for nonsurgically treated diabetic foot osteomyelitis: a multicenter open-label controlled randomized study. Diabetes Care 2015;38:302-307. Diabetes Care (2015) 1.99
Outcome and predictors of treatment failure in total hip/knee prosthetic joint infections due to Staphylococcus aureus. Clin Infect Dis (2011) 1.87
Severe imported falciparum malaria: a cohort study in 400 critically ill adults. PLoS One (2010) 1.86
WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus. Lancet Infect Dis (2007) 1.85
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. Intensive Care Med (2013) 1.74
Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa. Clin Infect Dis (2003) 1.69
The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire. Antivir Ther (2007) 1.68
Pharmacokinetics of etravirine, raltegravir and darunavir/ritonavir in treatment experienced patients. AIDS (2010) 1.65
Characteristics of and outcomes in HIV-infected patients who return to care after loss to follow-up. AIDS (2009) 1.62
Risk factors for anaemia in patients on prolonged linezolid therapy for chronic osteomyelitis: a case-control study. J Antimicrob Chemother (2004) 1.59
Laboratory monitoring to guide switching antiretroviral therapy in resource-limited settings: clinical benefits and cost-effectiveness. J Acquir Immune Defic Syndr (2010) 1.57
Resuscitation with low volume hydroxyethylstarch 130 kDa/0.4 is not associated with acute kidney injury. Crit Care (2010) 1.56
Predictors of extubation failure in patients with chronic obstructive pulmonary disease. J Crit Care (2006) 1.54
H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy. Gut (2011) 1.52
Average adherence to boosted protease inhibitor therapy, rather than the pattern of missed doses, as a predictor of HIV RNA replication. Clin Infect Dis (2010) 1.49
Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naive HIV-1-infected patients: final 5-year results from STARTMRK. J Acquir Immune Defic Syndr (2013) 1.48
Polycomb-group proteins repress the floral activator AGL19 in the FLC-independent vernalization pathway. Genes Dev (2006) 1.41
The Chikungunya epidemic on La Réunion Island in 2005-2006: a cost-of-illness study. PLoS Negl Trop Dis (2011) 1.41
Vascular graft infections in the intensive care unit: clinical spectrum and prognostic factors. J Infect (2010) 1.40
Long-term outcome of patients hospitalized in intensive care units with central or extrapontine myelinolysis*. Crit Care Med (2012) 1.40
HIV drug resistance surveillance for prioritizing treatment in resource-limited settings. AIDS (2007) 1.30
Newer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adults. AIDS (2012) 1.26
Switch from enfuvirtide to raltegravir in virologically suppressed multidrug-resistant HIV-1-infected patients: a randomized open-label trial. Clin Infect Dis (2009) 1.23
Risk factors of chronic kidney disease in HIV-infected patients. Clin J Am Soc Nephrol (2011) 1.21
Incidence rate and risk factors for loss to follow-up in HIV-infected patients from five French clinical centres in Northern France - January 1997 to December 2006. Antivir Ther (2009) 1.19
Factors associated with presentation to care with advanced HIV disease in Brussels and Northern France: 1997-2007. BMC Infect Dis (2011) 1.18
ANRS-COM'TEST: description of a community-based HIV testing intervention in non-medical settings for men who have sex with men. BMJ Open (2012) 1.16
Cost-effectiveness of primary prophylaxis of AIDS associated cryptococcosis in Cambodia. PLoS One (2010) 1.15
Missed opportunities for HIV testing in newly-HIV-diagnosed patients, a cross sectional study. BMC Infect Dis (2013) 1.14
Introduction of SARS in France, March-April, 2003. Emerg Infect Dis (2004) 1.10
PCR diagnosis of candidemia. J Crit Care (2013) 1.08
Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study. Crit Care (2007) 1.08
Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia. Intensive Care Med (2006) 1.06
Factors associated with virological failure in HIV-1-infected patients receiving darunavir/ritonavir monotherapy. J Infect Dis (2011) 1.06
Thrombocytosis in patients with severe community-acquired pneumonia. Chest (2010) 1.06
Impact of adequacy of initial antimicrobial therapy on the prognosis of patients with ventilator-associated pneumonia. Intensive Care Med (2003) 1.05
Rapid detection of glycopeptide-resistant enterococci: impact on decision-making and costs. Antimicrob Resist Infect Control (2013) 1.04
Increasing HIV-1 non-B subtype primary infections in patients in France and effect of HIV subtypes on virological and immunological responses to combined antiretroviral therapy. Clin Infect Dis (2012) 1.02
Impact of human immunodeficiency virus type 1 subtype on first-line antiretroviral therapy effectiveness. Antivir Ther (2005) 1.02
Estimates of opportunistic infection incidence or death within specific CD4 strata in HIV-infected patients in Abidjan, Côte d'Ivoire: impact of alternative methods of CD4 count modelling. Eur J Epidemiol (2007) 1.01
Long-term efficacy and safety of raltegravir, etravirine, and darunavir/ritonavir in treatment-experienced patients: week 96 results from the ANRS 139 TRIO trial. J Acquir Immune Defic Syndr (2012) 1.01
One-year mortality in patients requiring prolonged mechanical ventilation: multicenter evaluation of the ProVent score. Crit Care (2014) 1.00
Cancer-associated hypercalcemia treated with intravenous diphosphonates: a survival and prognostic factor analysis. Support Care Cancer (2007) 1.00
Retention in care for HIV-infected patients in the eye of the Ebola storm: lessons from Monrovia, Liberia. AIDS (2015) 0.99
Improved aero-anaerobe recovery from infected prosthetic joint samples taken from 72 patients and collected intraoperatively in Rosenow's broth. Acta Orthop (2006) 0.97
A pilot randomized study comparing high and low volume hemofiltration on vasopressor use in septic shock. Intensive Care Med (2008) 0.96
Prevention of surgical site infection after breast cancer surgery by targeted prophylaxis antibiotic in patients at high risk of surgical site infection. J Surg Oncol (2007) 0.96
Volume expansion in the first 4 days of shock: a prospective multicentre study in 19 French intensive care units. Intensive Care Med (2014) 0.95
Risk factors for early catheter-related infections in cancer patients. Cancer (2007) 0.94
Outcome of diabetic foot osteomyelitis treated nonsurgically: a retrospective cohort study. Diabetes Care (2008) 0.94
Introduction to late presentation for HIV treatment in Europe. Antivir Ther (2010) 0.94
Evaluation of "Candida score" in critically ill patients: a prospective, multicenter, observational, cohort study. Ann Intensive Care (2011) 0.94
An update to "The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe". Vaccine (2010) 0.94
Needle puncture and transcutaneous bone biopsy cultures are inconsistent in patients with diabetes and suspected osteomyelitis of the foot. Clin Infect Dis (2009) 0.94
Expected response to protease inhibitors of HIV-1 non-B subtype viruses according to resistance algorithms. AIDS (2008) 0.93
Resistance analyses in highly experienced patients failing raltegravir, etravirine and darunavir/ritonavir regimen. AIDS (2010) 0.92
A single HIV-1 cluster and a skewed immune homeostasis drive the early spread of HIV among resting CD4+ cell subsets within one month post-infection. PLoS One (2013) 0.92
Report of a European Working Group on late presentation with HIV infection: recommendations and regional variation. Antivir Ther (2010) 0.92
Economic evaluation of ART in resource-limited countries. Curr Opin HIV AIDS (2010) 0.92
It is time to change the paradigm for hepatitis C virus testing. Clin Infect Dis (2012) 0.90
Risk factors for syphilis infection in men who have sex with men: results of a case-control study in Lille, France. Sex Transm Infect (2012) 0.89
First initial community-acquired meningitis due to extended-spectrum beta-lactamase producing Escherichia coli complicated with multiple aortic mycotic aneurysms. Ann Clin Microbiol Antimicrob (2012) 0.88
Bone loss in patients with HIV infection. Joint Bone Spine (2009) 0.88
Is total community viral load a robust predictive marker of the efficacy of the TasP strategy? J Acquir Immune Defic Syndr (2012) 0.88
Epidemiology and prognostic factors of critically ill patients treated with hemodiafiltration. J Crit Care (2006) 0.87
The European (ECCO) Consensus on infection in IBD: what does it change for the clinician? Gut (2009) 0.87
Thymidine analogue mutations in antiretroviral-naive HIV-1 patients on triple therapy including either zidovudine or stavudine. J Antimicrob Chemother (2003) 0.85
Tolerability of prolonged linezolid therapy in bone and joint infection: protective effect of rifampicin on the occurrence of anaemia? J Antimicrob Chemother (2010) 0.85
Severe community-acquired pneumonia: don't get rid of fluoroquinolone. Crit Care Med (2013) 0.85
Spondylodiscitis and an aortic aneurysm due to Campylobacter coli. Ann Clin Microbiol Antimicrob (2010) 0.84
Impact of thrombocytopenia on outcome of patients admitted to ICU for severe community-acquired pneumonia. J Infect (2007) 0.84